United Kingdom· GB-APID-3492811000001107
AC Vax vaccine powder and solvent for solution for injection vials
A medicinal product containing meningococcal groups a + c vaccine, registered in United Kingdom by GlaxoSmithKline UK Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Meningococcal groups A + C vaccine
- Manufacturer
- GlaxoSmithKline UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- October 2, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8e9f64f0-dbc2-4441-b381-520ad583ad33 GET /v1/drugs/8e9f64f0-dbc2-4441-b381-520ad583ad33?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "3492811000001107",
"desc": "AC Vax vaccine powder and solvent for solution for injection vials (GlaxoSmithKline UK Ltd)",
"form": "Powder and solvent for solution for injection",
"vpid": "3559211000001100",
"source": "dmd",
"vtm_id": "9896611000001103",
"strength": null,
"substance": "Meningococcal groups A + C vaccine",
"ingredient": "Neisseria meningitidis group C capsular polysaccharide",
"supplier_code": "4012301000001105"
}See everything about meningococcal groups a + c vaccine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.